|
|
|
Insider
Information: |
Patton John Stuart |
Relationship: |
Chief Scientific Offic... |
City: |
San Diego, |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
493,756 |
|
Indirect Shares
|
233,444 |
|
|
Direct
Value |
$8,396,930 |
|
|
Indirect Value
|
$10,203,618 |
|
|
Total
Shares |
727,200 |
|
|
Total
Value |
$18,600,547 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Halozyme Therapeutics Inc |
HALO |
Director |
2014-08-19 |
179,876 |
2005-01-18 |
232,830 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Chief Scientific Offic... |
2008-11-14 |
313,880 |
2006-05-15 |
614 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
Director |
|
2007-04-11 |
4 |
AS |
$8.46 |
$215,390 |
D/D |
(25,000) |
237,471 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2007-04-18 |
4 |
AS |
$8.97 |
$228,341 |
D/D |
(25,000) |
212,471 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2013-09-13 |
4 |
S |
$9.10 |
$341,359 |
D/D |
(37,500) |
192,500 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2013-09-16 |
4 |
S |
$9.16 |
$343,680 |
D/D |
(37,500) |
155,000 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
|
2004-01-13 |
4 |
AS |
$18.18 |
$363,733 |
I/I |
(20,000) |
547,308 |
|
- |
|
NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
|
2004-02-10 |
4 |
AS |
$20.00 |
$400,000 |
I/I |
(20,000) |
527,308 |
|
- |
|
NKTR |
Nektar Therapeutics |
officerTitle |
|
2006-01-13 |
4 |
AS |
$20.00 |
$400,716 |
I/I |
(20,000) |
513,657 |
|
- |
|
NKTR |
Nektar Therapeutics |
officerTitle |
|
2006-01-27 |
4 |
AS |
$22.00 |
$440,000 |
I/I |
(20,000) |
551,657 |
|
- |
|
NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
|
2004-03-04 |
4 |
AS |
$22.00 |
$443,522 |
I/I |
(20,000) |
507,308 |
|
- |
|
NKTR |
Nektar Therapeutics |
officerTitle |
|
2006-01-19 |
4 |
OE |
$19.37 |
$452,386 |
I/I |
23,355 |
571,657 |
|
- |
|
NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
|
2005-01-14 |
4 |
OE |
$18.61 |
$588,076 |
I/I |
31,600 |
534,878 |
|
- |
|
NKTR |
Nektar Therapeutics |
officerTitle |
|
2006-01-18 |
4 |
OE |
$19.32 |
$669,341 |
I/I |
34,645 |
548,302 |
|
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2014-08-19 |
4 |
S |
$9.96 |
$746,985 |
D/D |
(75,000) |
179,876 |
0 |
- |
|
63 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|